CAN Community Health Welcomes Marlon Pittman to its Board of Directors

SARASOTA, Fla., Jan. 10, 2022 /PRNewswire-PRWeb/ -- CAN Community Health announces the appointment of veteran pharmaceutical industry executive Marlon Pittman to its Board of Directors.

Mr. Pittman has 30 years of sales and market development experience in the pharmaceutical industry with expertise in the HIV healthcare and 340B pharmacy segments. From 2009 to 2018 he led the ViiV Healthcare sales team at GlaxoSmithKline, participating in the launch of several HIV medications, including Tivicay™, Triumeq™, and Juluca™.

In 2019 Mr. Pittman served as Business Development Director for CAN Community Health, assisting with the nonprofit's expansion into the Southern and Western United States. He currently serves as Sales Vice President for New Jersey-based Aquestive Therapeutics.

Jackie Rogers, Chairwoman of the CAN Board of Directors, said, "Marlon's clearly demonstrated experience in the medical and pharmaceutical industries has been invaluable in fortifying our ongoing expansion into new communities that have been identified as HIV 'hot spots.' His ability to communicate clearly with subject matter experts in 340B practices is helping us refine patient care strategies. We're delighted to welcome him to the Board."

About CAN Community Health:

CAN Community Health (CAN) is a not-for-profit, community-based organization with clinics in Florida, Arizona, New Jersey, South Carolina, Texas, and Virginia. CAN provides medical, pharmacy, dental, case management, mental health, and comprehensive prevention and services such as nPEP, PrEP, and education. CAN also provides screening and treatment for Hepatitis C and STDs, as well as transgender health services.

CAN provides services through Ryan White grants, STD prevention funding and the 340B Federal Drug Discount Program, which is a vital lifeline for safety-net providers caring for vulnerable communities, including HIV/AIDS providers participating in the Ryan White and STD programs. 340B covered entities provide high quality, accessible and affordable health care regardless of patients' ability to pay. The 340B program allows CAN to stretch resources and provide a full continuum of care to underserved and uninsured patients, including people living with HIV/AIDS and Hepatitis C.

With access to programs like these, CAN is able to provide quality care, increase viral suppression, lower rates of STD/Hep C infections and improve quality of life in communities, and continues to seek collaborative relations with local, state and national partners to remove treatment barriers for all individuals in care.

Media Contact

Steve Smith, Consonant Custom Media, +1 (941) 920-4284, [email protected]

SOURCE CAN Community Health